Induction of endothelial cell apoptosis by anti-alpha-enolase antibody.

Chin Med Sci J

Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Beijing 100730, China.

Published: September 2011

Objective: To assess the prevalence of anti-alpha-enolase antibody in systemic autoimmune diseases in Chinese patients and its role in endothelial cell apoptosis.

Methods: The reactivity of anti-alpha-enolase antibody in a variety of autoimmune disorders in Chinese patients was evaluated by dot blot assay. Endothelial cell apoptosis was investigated by in vitro incubation of endothelial cells with IgG purified from anti-alpha-enolase antibody-positive sera, with or without pre-incubation with recombinant alpha-enolase.

Results: Anti-alpha-enolase antibody was prevalent in different systemic autoimmune diseases with relatively high reactivity in Chinese patients. In vitro incubation of endothelial cells with IgG containing anti-alpha-enolase antibody induced apoptosis in a time- and dose-dependent manner. Apoptosis was partly inhibited by pre-incubation of the endothelial cells with recombinant alpha-enolase.

Conclusions: Our data suggest that alpha-enolase is a common auto-antigen recognized by anti-endothelial cell antibodies in connective tissue disease. Interaction between alpha-enolase and its autoantibody plays a role in endothelial cell apoptosis. Changes other than cell killing may contribute to the pathogenesis of endothelial damage and microvascular lesions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1001-9294(11)60040-0DOI Listing

Publication Analysis

Top Keywords

anti-alpha-enolase antibody
20
endothelial cell
16
cell apoptosis
12
chinese patients
12
endothelial cells
12
systemic autoimmune
8
autoimmune diseases
8
role endothelial
8
vitro incubation
8
incubation endothelial
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!